Works matching IS 03331024 AND DT 2021 AND VI 41 AND IP 10


Results: 9
    1
    2
    3

    Dose selection for fremanezumab (AJOVY) phase 3 pediatric migraine studies using pharmacokinetic data from a pediatric phase 1 study and a population pharmacokinetic modeling and simulation approach.

    Published in:
    Cephalalgia, 2021, v. 41, n. 10, p. 1065, doi. 10.1177/03331024211007789
    By:
    • Cohen-Barak, Orit;
    • Radivojevic, Andrijana;
    • Jones, Aksana;
    • Fiedler-Kelly, Jill;
    • Gillespie, Michael;
    • Brennan, Michael;
    • Gutman, Dikla;
    • Rasamoelisolo, Michele;
    • Hallak, Hussein;
    • Loupe, Pippa;
    • Kessler, Yoel;
    • Ning, Xiaoping;
    • Levi, Micha;
    • Ahn, Andrew H;
    • Rabinovich-Guilatt, Laura
    Publication type:
    Article
    4

    Determinants of pain interference and headache impact in patients who have chronic migraine with medication overuse: Results from the MOTS trial.

    Published in:
    Cephalalgia, 2021, v. 41, n. 10, p. 1053, doi. 10.1177/03331024211006903
    By:
    • Schwedt, Todd J;
    • Sahai-Srivastava, Soma;
    • Murinova, Natalia;
    • Birlea, Marius;
    • Ahmed, Zubair;
    • Digre, Kathleen;
    • Lopez, Kristina;
    • Mullally, William;
    • Blaya, Maike Tiede;
    • Pippitt, Karly;
    • Cutrer, Fred Michael;
    • DeLange, Justin;
    • Schecht, Howard;
    • Rizzoli, Paul;
    • Lane, Judy;
    • Wald, John;
    • Cortez, Melissa M;
    • Martin, Vincent T;
    • Spare, Nicole M;
    • Hentz, Joseph G
    Publication type:
    Article
    6
    8
    9